Table IV.
Patient's interval and diagnostic interval of symptomatic second cancers (n = 40).
| Interval | Total n (%) | Brain tumors n (%) | BCC n (%) |
| Patient's interval | |||
| ≤ 1 week | 14 (35%) | 8 (57%) | |
| 1 week–1 month | 10 (25%) | 3 (21.5%) | 2 (20%) |
| 1 month–3 months | 4 (10%) | 2 (20%) | |
| 3 months–6 months 6 months–1 year |
2 (5%) | ||
| ≥ 1 year | 10 (25%) | 3 (21.5%) | 6 (60%) |
| Total | 40 | 14 | 10 |
| Diagnostic interval | |||
| ≤ 1 week | 14 (35%) | 7 (50%) | 2 (20%) |
| 1 week–1 month | 16 (40%) | 7 (50%) | 7 (70%) |
| 1 month–3 months | 4 (10%) | ||
| 3 months–6 months 6 months–1 year |
5 (12.5%) | ||
| ≥ 1 year | 1 (2.5%) | 1 (10%) | |
| Total | 40 | 14 | 10 |
Notes: Patient's interval: time period between the CCS first noticing symptoms and first visit to a physician. Diagnostic interval: time period between presentation to a physician and the diagnosis.